1. Market Research
  2. > Pathology
About 200 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Compounding Pharmacies Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 260 pages

Compounding Pharmacies Market: World Market Analysis By Product Type, By Therapeutic Area, By End User, By Region, By Country (2019 Edition): Forecast to 2024 Dermatology and Others) India, Brazil and Mexico.

  • Cardiovascular Disease
  • Lymphoma
  • Pharmacy
  • World
  • Market Size

Global Nuclear Medicine Market - Opportunities and Forecast (2013-2023)

  • $ 2400
  • January 2019
  • 244 pages

lymphoma where as samarium-##-EDTMP, and strontium-##-chloride for palliation of bone metastases.

  • Cardiovascular Disease
  • Lymphoma
  • Pathology
  • World
  • Cardinal Health, Inc.

Global Regenerative Medicine Market - Opportunities and Forecast

  • $ 2400
  • August 2019
  • 326 pages

This strategic acquisition will further promote Gilead as an industry leader in refractory large B-cell lymphoma after two or more lines of therapy.

  • Biopharmaceutical
  • Cardiovascular Disease
  • Lymphoma
  • Regenerative Medicine
  • Market Size

North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Pfizer Inc. has received the European Commission (EC) for its Lorviqua for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).

  • Cardiovascular Disease
  • Lymphoma
  • Pharmaceutical
  • North America
  • United States

Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type, Drug Type, Indication, Channel

  • $ 2400
  • June 2018
  • 240 pages

lymphoma Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma Pfizer Utomilumab Human IgG## CD## Phase ## Hoffmann-La Roche Polatuzumab vedotin Humanized IgG## ADC CD##b Phase ## Viventia Bio Oportuzumab monatox Humanized scFv immunotoxin EpCAM Phase ## Bladder cancer S

  • Cardiovascular Disease
  • Endocrine Disease
  • Lymphoma
  • World
  • Baxter International Inc.

Europe Pharmaceutical Drug Delivery Market Forecast to 2027 - Covid-19 Impact and Regional Analysis By  Route of Administration ; Application ; End User ; and Country

  • $ 3000
  • June 2020
  • 145 pages

Novartis has received the US Food and Drug Administration (FDA) approved for the Zykadia, which is used for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)positive.

  • Cardiovascular Disease
  • Lymphoma
  • Pharmaceutical
  • Forecast
  • GlaxoSmithKline plc

Vascular Access Device Market: World Market - Opportunities and Forecast (2014-2024)

  • $ 2400
  • July 2019
  • 300 pages

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the ...

  • Cardiovascular Disease
  • Drug Delivery
  • Injectable Delivery
  • Lymphoma
  • World

Global Surgical Ablation Market 2017-2021

  • $ 2500
  • June 2017
  • 93 pages

There are distinct types of cancers such as skin, breast, colorectal, lung, lymphoma, and prostate cancers.

  • Cardiovascular Disease
  • Health Services
  • Lymphoma
  • Boston Scientific Corporation
  • Medtronic, Inc.

Global Cardiovascular Disease Drugs Market to 2023 - Expiries, Acquisitions and New Products for Deep Vein Thrombosis, Pulmonary Arterial Hypertension and Dyslipidemia to Shake-Up the Competitive Landscape

  • $ 4995
  • December 2017
  • 228 pages

Lymphoma ## Activator Undisclosed Undisclosed Phosphodiesterase ## Inhibitor Undisclosed Prostaglandin G/ H Synthase ## Inhibitor, Voltage Dependent L Type Calcium Channel Blocker Type ## Angiotensin II Receptor Antagonist, Voltage Dependent L Type Calcium Channel Blocker Undisclosed LG Lif

  • Cardiovascular Disease
  • Chronic Disease
  • Lymphoma
  • Pathology
  • Merck & Co., Inc.

Acute Ischemic Stroke: Epidemiology Forecast to 2027

  • $ 3995
  • July 2018
  • 50 pages

Acute Ischemic Stroke: Epidemiology Forecast to 2027 Summary Acute Ischemic Stroke (AIS) occurs due to an obstructed blood vessel that supplies blood to the brain, and is the predominant type of stroke, ...

  • Cardiovascular Disease
  • Epidemiology
  • Hospital
  • Lymphoma
  • Stroke

National Institute of Neurological Disorders and Stroke - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 68 pages

a postdoctoral fellow in the Lieberman Lab, received The Leukemia & Lymphoma Society Career Development Fellow Award for $##, ## over three years to support a research project on the functions of an Epstein-Barr virus protein called EBNA## in regulating host gene expression.

  • Cardiovascular Disease
  • Lymphoma
  • Neurological Disorder
  • Stroke
  • United States

Frontier Pharma: Cardiovascular Disease - Diverse First-in-Class Molecular Targets to Bridge Unmet Needs in Pulmonary Hypertension, Heart Failure and Atherosclerosis

  • $ 6995
  • August 2017
  • 113 pages

Lymphoma ## Bifunctional Epoxide Hydrolase ##, Plasminogen B Cell Lymphoma ##, Brain Derived Neurotrophic Factor, CaM Kinase, Peroxisome Proliferator Activated Receptor Gamma Adrenomedullin Apoptosis Regulator BAX, Free Radical, Insulin Like Growth Factor I, Insulin Like Growth

  • Cardiovascular Disease
  • Chronic Disease
  • Lymphoma
  • Pathology
  • Therapy

Global Blood coagulation analyzer market 2016-2020

  • $ 2500
  • June 2016
  • 67 pages

There is a rising demand for blood testing due to an increase in the number of patients suffering from medical conditions such as blood disorders, CVDs, and blood cancers such as lymphoma, leukemia, and myeloma.

  • Cardiovascular Disease
  • Coagulation Diagnostic
  • Lymphoma
  • Roche Group
  • Sysmex Corporation

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • $ 4995
  • October 2016
  • 192 pages

Lymphoma ## Activator Undisclosed Small molecule Type ## Angiotensin II Receptor Small molecule Small molecule Small molecule eleclazine Gilead Sciences Phase III Phase III Phase III Phase III (atorvastatin calcium + metformin hydrochloride) XR CJ HealthCare (amlodipine besylate + candesartan

  • Cardiovascular Disease
  • Chronic Disease
  • Lymphoma
  • Pathology
  • Therapy

Radiofrequency Ablation Devices Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product Application, and Geography

  • $ 4550
  • April 2020
  • 145 pages

Radiofrequency Ablation Devices Market Forecast to 2027 - Covid-## Impact and Global Analysis Management), and Geography By Product (Devices, Disposables) Application (Surgical Oncology, Cardiology, Gynecology, Cosmetology and Pain LIST OF TABLES Table ##.

  • Cardiovascular Disease
  • General Medicine And Specialty Medicine
  • Lymphoma
  • Oncology
  • Forecast

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H1 2018

  • $ 3500
  • June 2018
  • 123 pages

THE MOST COMMON LYMPHOMA SUBTYPES ACCRUED WERE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL, ## PERCENT), FOLLICULAR LYMPHOMA (FL, ## PERCENT) AND HODGKIN LYMPHOMA (HL, ## PERCENT).

  • Cancer
  • Cardiovascular Disease
  • Lymphoma
  • Pharmaceutical
  • Therapy

Pharmaceutical Drug Delivery Market by Route, Application, Patient Care Setting - Global Forecast to 2023

  • $ 4950
  • March 2019
  • 290 pages

LYMPHOMA B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA ROUTINE PROPHYLAXIS TO PREVENT HEREDITARY ANGIOEDEMA (HAE) ATTACKS HERPES ZOSTER (SHINGLES) INSTITUTO GRIFOLS, S. A.

  • Cardiovascular Disease
  • Drug Delivery
  • Lymphoma
  • North America
  • United States

Bromodomain Containing Protein 4 - Pipeline Review, H1 2020

  • $ 3500
  • February 2020
  • 143 pages

THE MOST COMMON LYMPHOMA SUBTYPES ACCRUED WERE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL, ## PERCENT), FOLLICULAR LYMPHOMA (FL, ## PERCENT) AND HODGKIN LYMPHOMA (HL, ## PERCENT).

  • Cardiovascular Disease
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Resverlogix Corp.

Pulmonary Hypertension - Global Market Research 2015-2019

  • $ 2500
  • September 2015
  • 65 pages

TECHNAVIO.

  • Cardiovascular Disease
  • Lymphoma
  • Therapy
  • Actelion Ltd
  • Bayer AG

Interleukin 1 - Pipeline Review, H1 2020

  • $ 3500
  • January 2020
  • 137 pages

THE DRUG CANDIDATE IS IN PHASE I/ II STAGE OF DEVELOPMENT FOR THE TREATMENT OF PROSTATE CANCER, COLORECTAL CANCER, OVARIAN CANCER, ESOPHAGEAL CANCER, NON-SMALL LUNG CANCER, FALLOPIAN TUBE CANCER AND LYMPHOMA.

  • Cardiovascular Disease
  • Dermatological Condition
  • Hospital
  • Lymphoma
  • Therapy
View report >

Healthcare Demographic Impact in California (USA)

  • May 2019
  • 47 pages

2019 Community Health Needs Assessment Adopted: May ##, 2019 ii List of Tables Table of Contents (cont. ) iii I.

  • Ambulatory Care
  • Cancer
  • Cardiovascular Disease
  • Healthcare
  • United States

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on